ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
17(1), P. 701 - 710
Published: Dec. 16, 2024
Controlling
CRISPR/Cas9
gene
editing
at
the
spatiotemporal
resolution
level,
especially
for
in
vivo
applications,
remains
a
great
challenge.
Here,
we
developed
near-infrared
(NIR)
light-activated
nanophotonic
system
(UCPP)
controlled
CRISPR-Cas9
and
synergistic
photodynamic
therapy
(PDT).
Lanthanide-doped
upconversion
nanoparticles
are
not
only
employed
as
carriers
intracellular
plasmid
delivery
but
also
serve
nanotransducers
to
convert
NIR
light
(980
nm)
into
visible
with
emission
460
650
nm,
which
could
result
simultaneous
activation
of
PDT
processes,
respectively.
Such
unique
design
achieves
light-controlled
precise
hypoxia-inducible
factor
1α
minimal
off-target
effect,
effectively
ameliorates
hypoxic
state
tumor
sites,
facilitates
deep-seated
process
antitumor
effect.
This
optogenetically
activatable
nanosystem
holds
potential
spatially
targeted
cancer
therapy.
ACS Applied Bio Materials,
Journal Year:
2024,
Volume and Issue:
7(10), P. 6970 - 6984
Published: Oct. 1, 2024
Bacterial
resistance
to
antibiotics
can
negatively
affect
the
treatment
of
infected
skin
wounds.
The
combination
synergistic
antibacterial
therapies
with
photodynamic,
photothermal,
and
chemodynamic
has
been
recognized
as
one
most
promising
approaches.
In
this
study,
we
have
developed
MSN@Ce6@MnO
ACS Applied Materials & Interfaces,
Journal Year:
2024,
Volume and Issue:
17(1), P. 701 - 710
Published: Dec. 16, 2024
Controlling
CRISPR/Cas9
gene
editing
at
the
spatiotemporal
resolution
level,
especially
for
in
vivo
applications,
remains
a
great
challenge.
Here,
we
developed
near-infrared
(NIR)
light-activated
nanophotonic
system
(UCPP)
controlled
CRISPR-Cas9
and
synergistic
photodynamic
therapy
(PDT).
Lanthanide-doped
upconversion
nanoparticles
are
not
only
employed
as
carriers
intracellular
plasmid
delivery
but
also
serve
nanotransducers
to
convert
NIR
light
(980
nm)
into
visible
with
emission
460
650
nm,
which
could
result
simultaneous
activation
of
PDT
processes,
respectively.
Such
unique
design
achieves
light-controlled
precise
hypoxia-inducible
factor
1α
minimal
off-target
effect,
effectively
ameliorates
hypoxic
state
tumor
sites,
facilitates
deep-seated
process
antitumor
effect.
This
optogenetically
activatable
nanosystem
holds
potential
spatially
targeted
cancer
therapy.